- Investing Ideas
- /
- Taiwanese Pharmaceuticals & Biotech Sustainable Track Record
Taiwanese Pharmaceuticals & Biotech Sustainable Track Record
Results
4
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
4 companies
TTY Biopharm
Market Cap: NT$17.4b
Engages in the development and sale of pharmaceutical and chemical drugs in Taiwan and internationally.
4105
NT$70.00
7D
-7.5%
1Y
-10.5%
PharmaEngine
Market Cap: NT$12.1b
A biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan.
4162
NT$84.00
7D
-15.0%
1Y
-13.5%
Lotus Pharmaceutical
Market Cap: NT$56.3b
Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.
1795
NT$212.00
7D
-8.6%
1Y
-38.0%
Bora Pharmaceuticals
Market Cap: NT$70.4b
Researches and develops, manufactures, distributes, and sells pharmaceuticals worldwide.
6472
NT$685.00
7D
-1.0%
1Y
-13.3%